Novo Nordisk will reduce U.S. list prices of several insulin products by up to 75% next year, following political pressure to lower prices. NoVo Nordisk Jumps on Insulin Price Reduction Bandwagon On Tuesday, Novo Nordisk (NOVOb.CO) announced it will cut the U.S. list prices of various insulin products by up to 75% in the coming year. This move comes in response to growing political pressure … Continue reading Insulin Prices Slashed by Novo Nordisk